117 related articles for article (PubMed ID: 7734494)
1. [Sensitivity of yeast isolates to amphotericin B and other antifungal inhibitors of beta-glucan synthesis].
García M; Nogués A; Herrero E
Enferm Infecc Microbiol Clin; 1995 Mar; 13(3):151-6. PubMed ID: 7734494
[TBL] [Abstract][Full Text] [Related]
2. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
Bartizal K; Abruzzo G; Trainor C; Krupa D; Nollstadt K; Schmatz D; Schwartz R; Hammond M; Balkovec J; Vanmiddlesworth F
Antimicrob Agents Chemother; 1992 Aug; 36(8):1648-57. PubMed ID: 1416847
[TBL] [Abstract][Full Text] [Related]
3. Effect of papulacandin B on glucan synthesis in Paracoccidioides brasiliensis.
Dávila T; San-Blas G; San-Blas F
J Med Vet Mycol; 1986 Jun; 24(3):193-202. PubMed ID: 3735029
[TBL] [Abstract][Full Text] [Related]
4. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Park BJ; Park JC; Taguchi H; Fukushima K; Hyon SH; Takatori K
Biochem Biophys Res Commun; 2006 Aug; 347(2):401-5. PubMed ID: 16831406
[TBL] [Abstract][Full Text] [Related]
5. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
6. In vitro interaction of micafungin with conventional and new antifungals against clinical isolates of Trichosporon, Sporobolomyces and Rhodotorula.
Serena C; Mariné M; Pastor FJ; Nolard N; Guarro J
J Antimicrob Chemother; 2005 Jun; 55(6):1020-3. PubMed ID: 15845779
[TBL] [Abstract][Full Text] [Related]
7. Acquired resistance to echinocandins in Candida albicans: case report and review.
Baixench MT; Aoun N; Desnos-Ollivier M; Garcia-Hermoso D; Bretagne S; Ramires S; Piketty C; Dannaoui E
J Antimicrob Chemother; 2007 Jun; 59(6):1076-83. PubMed ID: 17468115
[TBL] [Abstract][Full Text] [Related]
8. Papulacandin B resistance in budding and fission yeasts: isolation and characterization of a gene involved in (1,3)beta-D-glucan synthesis in Saccharomyces cerevisiae.
Castro C; Ribas JC; Valdivieso MH; Varona R; del Rey F; Duran A
J Bacteriol; 1995 Oct; 177(20):5732-9. PubMed ID: 7592316
[TBL] [Abstract][Full Text] [Related]
9. Glucan synthesis and its inhibition by cilofungin in susceptible and resistant strains of Candida albicans.
Angiolella L; Bromuro C; Simonetti N; Cassone A
J Med Vet Mycol; 1992; 30(5):369-76. PubMed ID: 1469538
[TBL] [Abstract][Full Text] [Related]
10. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
Carrillo-Muñoz AJ; Quindós G; Gasser I; Tur-Tur C; Ruesga MT; Alonso-Vargas R; Arévalo P; Bornay-Llinares FJ; Santos P; del Valle O
Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673
[TBL] [Abstract][Full Text] [Related]
11. Retinal toxicity and in vitro efficacy study of cilofungin (LY121019).
Shahsavari M; Peyman GA; Niesman MR
Ophthalmic Surg; 1990 Oct; 21(10):726-8. PubMed ID: 2250858
[TBL] [Abstract][Full Text] [Related]
12. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
Fujita S
Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of in vitro antifungal activity of ditiocarb sodium.
Allerberger F; Roberts G; Reisinger E; Dierich MP
Arzneimittelforschung; 1991 Apr; 41(4):443-8. PubMed ID: 1650228
[TBL] [Abstract][Full Text] [Related]
14. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
15. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B.
Meunier F; Lambert C; Van der Auwera P
J Antimicrob Chemother; 1989 Sep; 24(3):325-31. PubMed ID: 2681118
[TBL] [Abstract][Full Text] [Related]
17. The lipopeptide antimycotic, cilofungin modulates the incorporation of glucan-associated proteins into the cell wall of Candida albicans.
Angiolella L; Simonetti N; Cassone A
J Antimicrob Chemother; 1994 Jun; 33(6):1137-46. PubMed ID: 7928807
[TBL] [Abstract][Full Text] [Related]
18. [Determination of in vitro synergy when amphotericin B is combined with various antimicrobial agents against yeasts by using a colorimetric microdilution checkerboard].
Yamane N; Behiry IK; Tosaka M; Nakasone I
Rinsho Byori; 1997 Jul; 45(7):689-95. PubMed ID: 9256018
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
20. A whole-cell Candida albicans assay for the detection of inhibitors towards fungal cell wall synthesis and assembly.
Frost DJ; Brandt KD; Cugier D; Goldman R
J Antibiot (Tokyo); 1995 Apr; 48(4):306-10. PubMed ID: 7775267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
